{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL6",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0956" ],
      "Organ" : [ "uberon:UBERON:0001959" ],
      "CellType" : [ "cl:CL:0000786" ]
    }
  },
  "verbose_text" : "Plasma levels of human soluble IL6R and human IL6 were markedly increased at the end of a 4-week tocilizumab treatment in Il6ra hIL6R / hIL6R -hIL6 transgenic mice (XREF_FIG).",
  "reading_complete" : "2020-08-04T09:02:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:01:17Z",
  "trigger" : "levels",
  "evidence" : [ "levels of human soluble IL6R and human IL6" ],
  "pmc_id" : "3561642",
  "score" : 0
}